MicroRNA-939 regulating CD2-associated protein expression by targeting promoter
Yuping Huang, Lingzhi Qiu, Jingwen Xu, Liping Zhao, Ling Li, Guo‐Ping Zhou
Abstract
Yuping Huang, Lingzhi Qiu, Jingwen Xu, Liping Zhao, Ling Li, Guo‐Ping Zhou
Abstract
Objective To verify the targeting regulatory relationship between microRNA-939 (miR-939) and CD2-associated protein (CD2AP). Methods The online RegRNA software was used to predict the human CD2AP promoter for potential binding sites complementary to miR-939.HEK-293T cells were cotransfected with human CD2AP promoter plasmid pGL3-2K and microRNA negative control (miR-NC) or miR-939 mimics, and the relative luciferase activity(RLA) was detected at 24 h post-transfection.HEK-293T cells were transfected with miR-NC or miR-939 mimics for 48 h, and the CD2AP mRNA expression level was detected by adopting reverse transcript and real-time fluorescence quantification-PCR, while the CD2AP protein expression level was detected by using Western blot. Results (1) There were 2 miR-939 binding sites at CD2AP promoter region, located at -468 to -491 and -654 to -677 upstream of initiation codon ATG (marked as + 1) relatively.(2)At 30 nmol/L, 50 nmol/L, the RLA in miR-NC group and miR-939 group were 6.81±0.88 vs 6.07±2.24, 5.88±1.44 vs 3.94±0.79 relatively, and there were no significant differences between the 2 groups (t=3.04, 2.06, all P>0.05), while the RLA between the 2 groups were 5.58±0.58 vs 3.29±0.64 at 100 nmol/L, and the difference was significant between the 2 groups(t=4.07, P<0.05). (3) At 30 nmol/L, 50 nmol/L and 100 nmol/L, the relative CD2AP mRNA expression in miR-NC group and miR-939 group were 1.00±0.01 vs 0.80±0.08, 1.00±0.00 vs 0.80±0.13 and 1.00±0.00 vs 0.72±0.07 relatively, while the CD2AP mRNA expression was decreased by 20%-30% at each concentration level, and there were significant differences between the 2 groups (t=4.44, 2.93, 6.84, all P<0.05). (4) At 50 nmol/L, the relative CD2AP protein expression in miR-NC group and miR-939 group were 0.48±0.09 vs 0.19±0.12, and the CD2AP protein expression was decreased, and the difference was significant (t=3.36, P<0.05). Conclusions CD2AP is the target gene of miR-939, and miR-939 can down-regulate the expression of CD2AP both in mRNA and protein levels by targeting its promoter region, which indicates that miR-939 may mediate the podocyte injury. Key words: MicroRNA-939; CD2-associated protein; Podocyte; Promoter; Gene expression regulation
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To verify the targeting regulatory relationship between microRNA-939 (miR-939) and CD2-associated protein (CD2AP). Methods The online RegRNA software was used to predict the human CD2AP promoter for potential binding sites complementary to miR-939.HEK-293T cells were cotransfected with human CD2AP promoter plasmid pGL3-2K and microRNA negative control (miR-NC) or miR-939 mimics, and the relative luciferase activity(RLA) was detected at 24 h post-transfection.HEK-293T cells were transfected with miR-NC or miR-939 mimics for 48 h, and the CD2AP mRNA expression level was detected by adopting reverse transcript and real-time fluorescence quantification-PCR, while the CD2AP protein expression level was detected by using Western blot. Results (1) There were 2 miR-939 binding sites at CD2AP promoter region, located at -468 to -491 and -654 to -677 upstream of initiation codon ATG (marked as + 1) relatively.(2)At 30 nmol/L, 50 nmol/L, the RLA in miR-NC group and miR-939 group were 6.81±0.88 vs 6.07±2.24, 5.88±1.44 vs 3.94±0.79 relatively, and there were no significant differences between the 2 groups (t=3.04, 2.06, all P>0.05), while the RLA between the 2 groups were 5.58±0.58 vs 3.29±0.64 at 100 nmol/L, and the difference was significant between the 2 groups(t=4.07, P<0.05). (3) At 30 nmol/L, 50 nmol/L and 100 nmol/L, the relative CD2AP mRNA expression in miR-NC group and miR-939 group were 1.00±0.01 vs 0.80±0.08, 1.00±0.00 vs 0.80±0.13 and 1.00±0.00 vs 0.72±0.07 relatively, while the CD2AP mRNA expression was decreased by 20%-30% at each concentration level, and there were significant differences between the 2 groups (t=4.44, 2.93, 6.84, all P<0.05). (4) At 50 nmol/L, the relative CD2AP protein expression in miR-NC group and miR-939 group were 0.48±0.09 vs 0.19±0.12, and the CD2AP protein expression was decreased, and the difference was significant (t=3.36, P<0.05). Conclusions CD2AP is the target gene of miR-939, and miR-939 can down-regulate the expression of CD2AP both in mRNA and protein levels by targeting its promoter region, which indicates that miR-939 may mediate the podocyte injury. Key words: MicroRNA-939; CD2-associated protein; Podocyte; Promoter; Gene expression regulation
Key concepts: HEK 293 cells, Transfection, Luciferase, Western blot, Molecular biology, microRNA, Messenger RNA, Biology